Michael Günther1,2*Robert Rockenfeller3Harald Walach4,5 In Germany, a consortium of authority-accredited laboratories (ALM) covered approximately 90% of all severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) tests during…[...]
Read More
LAURAN NEERGAARD CAR-T therapy was originally developed for leukemias and lymphomas, and the breakthrough treatment is now also being used for autoimmune diseases. Here’s a look at how the powerful…[...]
Read More
By Editorial Team - One Day MD.com More than four years following the emergence of COVID-19, a subset of individuals experience persistent, multisystem symptoms extending beyond three months post-infection or post-exposure to…[...]
Read More
John Murphy, CEO COVID-19 Long-haul foundation I. Introduction: The Immune System Under Siege The immune system is a dynamic, multilayered defense network composed of innate and adaptive components, designed to…[...]
Read More
Author: John Murphy, MD CEO & President, COVID-19 Long-haul Foundation Abstract Vertigo and disequilibrium are increasingly recognized as disabling sequelae of Long COVID, yet remain under-characterized in clinical literature. This…[...]
Read More
Abdullah M. Almutairi • Mushabab A. Alshahrani • Khalid A. Albalawi et.al., DOI: 10.7759/cureus.95744 Abstract Coronavirus disease 2019 (COVID-19) vaccines have been instrumental in mitigating the pandemic, but rare post-vaccination immune-related events have been reported. Due…[...]
Read More
Author: John Murphy, CEO COVID 19 Long-haul Foundation Abstract The SARS-CoV-2 spike glycoprotein, central to viral entry and the target of mRNA vaccine platforms, has emerged as a persistent antigen…[...]
Read More
Author: John Murphy, President, COVID-19 Long-haul Foundation Abstract Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), is characterized by persistent symptoms affecting multiple organ systems. Among its most compelling…[...]
Read More
Andrea Polli, Lode Godderis, Dries S. Martens, et. al., , BMC Medicine volume 23, Article number: 60 (2025) Cite this article Abstract Background Long-COVID is defined as the persistency or development of new symptoms 3 months after the initial SARS-CoV-2…[...]
Read More
Reactive arthritis can develop after COVID-19 due to immune system activation. The virus triggers inflammation that may mistakenly target joint tissues, even if joints weren’t affected during the acute illness2.…[...]
Read More